Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Amputation (1)
- Bremelanotide (1)
- Cerebral vascular accident (1)
- Cobicistat (1)
- Darunavir (1)
-
- Diabetes (1)
- Emcitrabine (1)
- Food-insecurity (1)
- HIV-1 (1)
- Headache (1)
- Hypoactive sexual desire disorder (1)
- Lifestyle (1)
- Low-risk (1)
- Microvascular complications (1)
- Mirror neurons (1)
- Neuroimaging (1)
- Neuropathy (1)
- Nonacute (1)
- Pseudobulbar affect (1)
- Reassurance (1)
- Referral (1)
- Salvage (1)
- Scales and measures (1)
- Septic diabetic foot (1)
- Tenofovir alafenamide (1)
- Theory of the mind (1)
- Virologically suppressed HIV (1)
Articles 1 - 6 of 6
Full-Text Articles in Medicine and Health Sciences
Dextromethorphan-Quinidine Is Helpful For Pseudobulbar Affect Disorder In Stroke Patients, Michael Francis, Mira Hamame, Md, Mariam Nasrallah, Md, Alison Nesbitt, Do, James Peter Meza, Md, Phd
Dextromethorphan-Quinidine Is Helpful For Pseudobulbar Affect Disorder In Stroke Patients, Michael Francis, Mira Hamame, Md, Mariam Nasrallah, Md, Alison Nesbitt, Do, James Peter Meza, Md, Phd
Clinical Research in Practice: The Journal of Team Hippocrates
An informed consent article using
Hammond FM, Alexander DN, Cutler AJ, et al. PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology. 2016;16:89. https://doi.org/10.1186/s12883-016-0609-0
for a patient with pseudobulbar affect following stroke
Neuroimaging Referral For Reassurance In Evaluation Of Headache With Low-Risk Features, Omar E. Fernandez
Neuroimaging Referral For Reassurance In Evaluation Of Headache With Low-Risk Features, Omar E. Fernandez
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Howard L, Wessely S, Leese M, et al. Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache. J Neurol Neurosurg Psychiatry. 2005;76(11):1558-1564. https://doi.org/10.1136/jnnp.2004.057851
for a patient with daily headache.
Lifestyle Intervention Is Superior To Metformin In Prevention Of Microvascular Complications Of Diabetes In Women, But Socioeconomic Barriers May Lead To Use Of Combination, Katanya C. Alaga, Jesse Haddad
Lifestyle Intervention Is Superior To Metformin In Prevention Of Microvascular Complications Of Diabetes In Women, But Socioeconomic Barriers May Lead To Use Of Combination, Katanya C. Alaga, Jesse Haddad
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using
Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: The Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. https://doi.org/10.1016/S2213-8587(15)00291-0
for a patient with pre-diabetes who is concerned about the prevention of microvascular complications through lifestyle intervention while managing her busy schedule as a traveling house cleaner.
Limb Salvage Therapy In Septic Diabetic Foot Ulcer In Patients Unwilling To Undergo Amputation, Luke Hong
Limb Salvage Therapy In Septic Diabetic Foot Ulcer In Patients Unwilling To Undergo Amputation, Luke Hong
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report appraising
Shojaiefard A, Khorgami Z, Larijani B. Septic diabetic foot is not necessarily an indication for amputation. J Foot Ankle Surg. 2008;47(5):419-423. https://doi.org/10.1053/j.jfas.2008.05.005
for a patient with a septic diabetic foot.
Using A Single Tablet Regimen Of Darunavir, Cobicistat, Emcitrabine, And Tenofovir Alafenamide In Virally Suppressed Hiv-1 Patients Is An Adequate Treatment Option For Controlling Hiv, Priya Kathuria
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Orkin C, Molina JM, Negredo E, et al. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial. Lancet HIV. 2018;5(1):e23-e34. https://doi.org/10.1016/S2352-3018(17)30179-0
for a patient with viriologically suppressed HIV-1.
There Is Insufficient Evidence To Recommend Bremelanotide For Hypoactive Sexual Desire Disorder, Scott Yaekle Md, Halima Ali Md, Carol Baker Md
There Is Insufficient Evidence To Recommend Bremelanotide For Hypoactive Sexual Desire Disorder, Scott Yaekle Md, Halima Ali Md, Carol Baker Md
Clinical Research in Practice: The Journal of Team Hippocrates
An informed consent discussion for a patient with Hypoactive Sexual Desire Disorder.